Portfelj
prim.
Tatjana Zekić
dr.med.
Medicinski fakultet
Katedra za internu medicinu
Kontakt
Vidljivost
Obrazovanje
2001.
MD
medicine
University of Rijeka - Faculty of Medicine
Radno iskustvo
3.2023.
Primarius, Internal medicine
KBC Rijeka
01.10.2019.
Teaching assistent
FACULTY OF MEDICINE RIJEKA
2019.
Rheumatology subspecialty
CHC RIJEKA
2012.
Internal medicine specialist
CHC RIJEKA
2007.
Internal medicine resident
CHC RIJEKA
Nagrade i priznanja
2019.
Top reviewer award in Clinical Medicine and Cross-Field : Publons.
2018.
Top reviewer award in Clinical Medicine -Publons.
Članstva
2021.
Croatian medical chamber, Croatian society of Rheumatology, SLEuro
2013.
EUSTAR
Nastavna djelatnost
Kolegiji
2020. -
Integrated undergraduate and graduate university study of Medicine
Internal medicine
Faculty of medicine
Lecturer
2019.
Propedeutika interne medicine, Interna medicina
preddiplomski
Medicinski fakultet u Rijeci, KBC Rijeka
predavač, asistent
Znanstvena djelatnost
Znanstveni radovi
2023.
Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease
Tatjana Zekić
Rheumatology
https://link.springer.com/article/10.1007/s00296-023-05302-9
Q2
2023.
Anti-programmed death-1 inhibitor nivolumab- induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review // Rheumatology International, 43 (2022), 3; 559-565 doi:10.1007/s00296-022-05247-5 (međunarodna recenzija, članak, znanstveni)
Zekić, Tatjana; Benić, Stanić Mirjana
Rheumatology
https://link.springer.com/article/10.1007/s00296-022-05247-5#citeas
Q2
2022.
Treatment of rheumatoid arthritis with conventional, targeted and biological disease- modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease // Rheumatology International, 42 (2022), 10; 1665-1679 doi:10.1007/s00296-022-05143-y
Zekić, Tatjana; Benić, Stanić Mirjana; Radić, Mislav
Rheumatology
https://link.springer.com/article/10.1007/s00296-022-05143-y
Q2
2021.
Bone Phenotyping Approaches in Human, Mice and Zebrafish – Expert Overview of the EU Cost Action GEMSTONE (“GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork”) // Frontiers in Endocrinology, 12 (2021), 2, 32 doi:10.3389/fendo.2021.720728
Foessl, Ines; Bassett, J. H. Duncan; Bjørnerem, Åshild; Busse, Björn; Calado, Ângelo; Chavassieux, Pascale; Christou, Maria; Douni, Eleni; Fiedler, Imke A. K.; Fonseca, João Eurico et al.
Osteoporosis, bone phenotyping
https://www.frontiersin.org/articles/10.3389/fendo.2021.720728/full
Q1
2019.
(Raynaud’s phenomenom as a first manifestation of high grade serosus carcinoma)
Turina, Sara; Novak, Srđan; Zekić, Tatjana; Babarović, Emina; Mihaljević Ferari, Ani; Eminović, Senija
Rheumatology
2018.
USPOREDBA UČINKOVITOSTI TOCILIZUMABA I INHIBITORA TNF-α U LIJEČENJU REUMATOIDNOG ARTRITISA // Reumatizam, 65 (2018), 1; 23-28 (domaća recenzija, članak, stručni)
Anić, Felina; Bašić, Marcela; Zekić, Tatjana; Defranceschi, Mladen; Novak, Srđan
Rheumatology
2018.
Cardiac involvement in eosinophilic granulomatosis with polyangiitis // Rheumatology international, 38 (2017), 706-706 doi:10.1007/s00296-017-3889-9
Tatjana Zekić
Rheumatology
Q2
2017.
The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients // Rheumatology International, 37 (2017), 12; 2105-2114 doi:10.1007/s00296-017-3843-x
Zekić, Tatjana; Stanić Benić, Mirjana; Antulov, Ronald; Antončić, Igor; Novak, Srđan
Rheumatology
https://link.springer.com/article/10.1007/s00296-017-3843-x
Q2
2014.
Kliničke manifestacije, dijagnoza i liječenje bolesnika s temporalnim arteritisom u Kliničkom bolničkom centru Rijeka
Šarić, Katarina; Šemper, Adriana; Anić, Felina; Zekić, Tatjana; Defranceschi, Mladen; Novak, Srđan
Rheumatology
Znanstveni skupovi
2009. -
https://www.bib.irb.hr/pretraga?operators=and%7Czeki%C4%87%2C%20tatjana%7Ctext%7Cprofile&page=1
x x